Page last updated: 2024-12-06

2-amino-3-methylimidazo(4,5-f)quinoline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-amino-3-methylimidazo(4,5-f)quinoline, also known as IQ, is a heterocyclic amine that is a potent mutagen and carcinogen. It is found in cooked meats, especially those cooked at high temperatures. IQ is formed during the cooking process through the reaction of creatinine and sugars with amino acids. The compound is a potent mutagen in bacterial and mammalian cells, and it has been shown to cause tumors in rodents. IQ is of significant interest to researchers because of its potential contribution to human cancer risk. Studies are ongoing to investigate the mechanisms of its toxicity, including its metabolism, DNA adduct formation, and cellular signaling pathways. Understanding the biological activity of IQ is crucial for developing strategies to mitigate its carcinogenic effects, such as reducing exposure to cooked meat and promoting healthy cooking practices.'
```

2-amino-3-methylimidazo(4,5-f)quinoline: mutagen found in broiled food; RN given refers to parent cpd; structure given in first source; frequently abbreviated as IQ in the literature [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

3-methyl-3H-imidazo[4,5-f]quinolin-2-amine : An imidazoquinoline that is 3H-imidazo[4,5-f]quinoline substituted by a methyl group at position 3 and an amino group at position 2. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID53462
CHEMBL ID1233049
CHEBI ID42725
SCHEMBL ID605923
MeSH IDM0093320

Synonyms (53)

Synonym
chebi:42725 ,
CHEMBL1233049
76180-96-6
2-amino-3-methylimidazo(4,5-f)-quinoline
3-methyl-3h-imidazo(4,5-f)quinolin-2-amine
2-amino-3-methylimidazo[4,5-f]quinoline
3h-imidazo(4,5-f)quinolin-2-amine, 3-methyl-
ccris 1767
hsdb 7085
2-amino-3-methyl-3h-imidazo(4,5-f)quinoline
n3-iq
brn 5014055
2-amino-3-methylimidazo(4,5-f)quinoline
3h-imidazo(4,5-f)quinoline, 2-amino-3-methyl-
2-amino-3-methylimidazo(4,5-f)- quinoline
2-amino-3-methylimidazo(4,5-f)quinoline hydrobromide
2-amino-3-methylimidazolo(4,5-f)quinoline
2-amiq
giq ,
3-methyl-3h-imidazo[4,5-f]quinolin-2-amine
iq
2-amino-3-methyl-3h-imidazo-[4,5-f]-quinoline
FT-0661919
FT-0661921
FT-0661920
3-methylimidazo[4,5-f]quinolin-2-amine
NCGC00248800-01
C19180
unii-30gl3d3t0g
30gl3d3t0g ,
dtxsid4020745 ,
cas-76180-96-6
NCGC00258247-01
tox21_200693
dtxcid00745
2-amino-3-methyl-3h-imidazo[4,5-f]quinoline
(3-methyl-3h-pyrido[3,2-e]benzoimidazol-2-yl)-amine
FT-0611062
SCHEMBL605923
2-amino-3-methylimidazo(4,5-f)quinoline [hsdb]
iq [iarc]
PS-3912
mfcd00210316
ARZWATDYIYAUTA-UHFFFAOYSA-N
AKOS026675474
2-amino-3-methyl-3h-imidazo[4 pound not5-f]quinoline
'2-amino-3-methylimidazo[4,5-f]quinoline'
3-methyl-3h-imidazo[4,5-f]quinolin-2-ylamine
Q27120486
2-amino-3-methyl-3h-imidazo[4,5-f]quinoline 10 microg/ml in acetonitrile
CS-0326450
PD061036
iq (iarc)

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The reactive N-hydroxylamine metabolites N-hydroxy-IQ and N-hydroxy-PhIP are toxic to isolated rat cardiomyocytes."( Protective effect of N-acetylcysteine against heterocyclic amine-induced cardiotoxicity in cultured myocytes and in rats.
Davis, CD; Snyderwine, EG, 1995
)
0.29
" The toxic effects of heterocyclic amines were also evaluated in rats given IQ or PhIP (100 mg/kg, po 10 doses over 2 weeks)."( Cardiotoxicity of heterocyclic amine food mutagens in cultured myocytes and in rats.
Davis, CD; Farb, A; Snyderwine, EG; Thorgeirsson, SS; Virmani, R, 1994
)
0.29

Compound-Compound Interactions

ExcerptReferenceRelevance
"025% 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) for two weeks combined with partial hepatectomy at the end of the first week and followed by long-term treatment with phenobarbital (PB) or 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB) from week 3 to week 86 resulted in dose-dependent development of liver and thyroid neoplastic and preneoplastic lesions."( Dose-dependent induction of liver and thyroid neoplastic lesions by short-term administration of 2-amino-3-methylimidazo[4,5-f]quinoline combined with partial hepatectomy followed by phenobarbital or low dose 3'-methyl-4-dimethylaminoazobenzene promotion.
Asamoto, M; Inoue, T; Ito, N; Nagao, M; Ogiso, T; Tsuda, H, 1988
)
0.27
"Mutagenic activity detected in beef extracts and in fried beef heated for varying periods of time was purified and then analysed by high-performance liquid chromatography in combination with mass spectrometry (LC-MS)."( Analysis of mutagenic heterocyclic amines in cooked beef products by high-performance liquid chromatography in combination with mass spectrometry.
Aeschbacher, HU; Bur, H; Huynh-Ba, T; Milon, H; Turesky, RJ, 1988
)
0.27

Dosage Studied

ExcerptRelevanceReference
" One polar metabolite present in the urine, IQ-sulphamate (39%), was found at considerably higher levels in rats dosed orally with IQ compared with those fed IQ (less than 6%)."( Metabolism of 2-amino-3-methylimidazo[4,5-f]quinoline in the male rat.
Inamasu, T; Luks, H; Vavrek, MT; Weisburger, JH, 1989
)
0.28
" Among the many blood proteins modified in rats dosed intragastrically with [3H(G)]IQ, hemoglobin and albumin were modified in a dose dependent fashion."( Binding of 2-amino-3-methylimidazo[4,5-f]quinoline to hemoglobin and albumin in vivo in the rat. Identification of an adduct suitable for dosimetry.
Skipper, PL; Tannenbaum, SR; Turesky, RJ, 1987
)
0.27
" N-Acetylcysteine pretreatment also significantly reduced the percentage of cardiac cells with T-tubule dilation and myelin figures in adult rats dosed with IQ."( Protective effect of N-acetylcysteine against heterocyclic amine-induced cardiotoxicity in cultured myocytes and in rats.
Davis, CD; Snyderwine, EG, 1995
)
0.29
" The finding of high cardiac IQ-DNA adduct levels prompted a histopathological study of perfusion-fixed hearts from 10 tumor-bearing monkeys chronically dosed with IQ at 10 mg/kg or 20 mg/kg 5 days per week for 48-80 months."( Cardiac damage induced by 2-amino-3-methyl-imidazo[4,5-f]quinoline in nonhuman primates.
Adamson, RH; Farb, A; Thorgeirsson, UP; Virmani, R, 1994
)
0.29
" In an ongoing carcinogenesis study, 34 out of 40 monkeys dosed with IQ have developed malignant liver tumors."( Liver tumors and possible preneoplastic lesions, induced by a food-derived heterocyclic amine in cynomolgus monkeys; a study of histology and cytokeratin expression.
Adamson, RH; Gomez, DE; Lindsay, CK; Sinha, CC; Thorgeirsson, UP, 1996
)
0.29
"This study describes histopathological findings in 26 nonhuman primates (cynomolgus and rhesus monkeys) with liver tumors after dosing with IQ for time periods of 27 to 72 months."( Histopathology of IQ-induced hepatocarcinogenesis in nonhuman primates.
Adamson, RH; Gomez, DE; Nagy, P; Sinha, CC; Thorgeirsson, UP, 1995
)
0.29
" Notably MeIQx is poorly activated in cynomolgus monkeys and lacks the potency of IQ to induce hepatocellular carcinoma after a 5-year dosing period."( Metabolism of food-derived heterocyclic amines in nonhuman primates.
Adamson, RH; Davis, CD; Nagao, M; Sadrieh, N; Schut, HA; Snyderwine, EG; Sugimura, T; Thorgeirsson, SS; Thorgeirsson, UP; Turesky, RJ; Turteltaub, KW, 1997
)
0.3
" The present study examined the dose-response for induction of CYP1A1 versus CYP1A2 by I3C, and compared the profiles of induction with the dose-response for inhibition of IQ-DNA adducts in the colon of the F344 rat."( Inhibition of 2-amino-3-methylimidazo[4,5-f]quinoline-DNA adducts by indole-3-carbinol: dose-response studies in the rat colon.
Bailey, GS; Bjeldanes, LF; Dashwood, RH; Schut, HA; Williams, DE; Xu, M, 1997
)
0.3
" The 2 week IQ dosing protocol was used in a second experiment in which male F344 rats from Simonsen Laboratories (SN) or NCI were fed AIN-93G, AIN-76A or chow diet."( Effect of carcinogen dose fractionation, diet and source of F344 rat on the induction of colonic aberrant crypts by 2-amino-3-methylimidazo[4,5-f]quinoline.
Chen, R; Dashwood, RH; Xu, M, 1999
)
0.3
" There were dose-response relationships of DNA adducts ((32)P-postlabeling) and DNA strand breaks (comet assay) in colon and liver tissues, with the highest levels of DNA adducts and strand breaks in the colon."( Mutagenicity of 2-amino-3-methylimidazo[4,5-f]quinoline in colon and liver of Big Blue rats: role of DNA adducts, strand breaks, DNA repair and oxidative stress.
Autrup, H; Daneshvar, B; Dragsted, LO; Hald, MT; Loft, S; Møller, P; Poulsen, HE; Risom, L; Vogel, U; Wallin, H, 2002
)
0.31
" Three hours after dosing with PhIP, PhIP-DNA adduct levels were statistically significantly lower in KO mice than in WT mice in all tissues examined."( Effect of CYP1A2 deficiency on heterocyclic amine DNA adduct levels in mice.
Kimura, S; Knight-Jones, L; Schut, HA; Snyderwine, EG; Yu, M, 2002
)
0.31
" In animals not dosed with IQ, sucrose increased the adduct level in both organs but to a lower level than IQ."( Effects of sucrose and cornstarch on 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)-induced colon and liver carcinogenesis in F344 rats.
Autrup, H; Dragsted, LO; Lindecrona, RH; Mølck, AM; Poulsen, M; Vogel, U, 2004
)
0.32
" We especially looked for any deviation from linearity of the dose-response curves."( A comparison of genotoxicity between three common heterocyclic amines and acrylamide.
Abramsson-Zetterberg, L; Durling, LJ, 2005
)
0.33
"01, respectively) in mice belonging to all EGCG dosing groups."( Protective effects of epigallocatechin gallate on colon preneoplastic lesions induced by 2-amino-3-methylimidazo[4,5-f ] quinoline in mice.
Li, YQ; Yang, XY; Yuan, JH,
)
0.13
" This result indicates the importance of dosage when interpreting data on the carcinogenicity and metabolic activation of IQ."( Low-dose carcinogenicity of 2-amino-3-methylimidazo[4,5-f ]quinoline in rats: Evidence for the existence of no-effect levels and a mechanism involving p21(Cip / WAF1).
Fukushima, S; Hirose, M; Nakae, D; Takahashi, S; Tatematsu, M; Totsuka, Y; Tsuda, H; Wanibuchi, H; Wei, M, 2011
)
0.37
" The selected dosage was 5 mg/kg for both heterocyclic amines."( Impact of aqueous doash extract on urinary mutagenicity in rats exposed to heterocyclic amines.
Ioanndes, C; Jalal, JA; Khan, JA; Moselhy, SS, 2013
)
0.39
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
carcinogenic agentA role played by a chemical compound which is known to induce a process of carcinogenesis by corrupting normal cellular pathways, leading to the acquistion of tumoral capabilities.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
imidazoquinoline
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (12)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency67.46260.007215.758889.3584AID1224835
acetylcholinesteraseHomo sapiens (human)Potency45.13020.002541.796015,848.9004AID1347395; AID1347398
RAR-related orphan receptor gammaMus musculus (house mouse)Potency25.72830.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency20.61370.000714.592883.7951AID1259369
AR proteinHomo sapiens (human)Potency7.87630.000221.22318,912.5098AID1259247; AID743054
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency30.76910.001022.650876.6163AID1224838; AID1224839; AID1224893
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency43.19890.003041.611522,387.1992AID1159552; AID1159553; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency20.61370.001530.607315,848.9004AID1259401
pregnane X nuclear receptorHomo sapiens (human)Potency51.77920.005428.02631,258.9301AID1346982
aryl hydrocarbon receptorHomo sapiens (human)Potency6.57120.000723.06741,258.9301AID743085; AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency14.59340.001723.839378.1014AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency51.77920.001628.015177.1139AID1259385
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (463)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990109 (23.54)18.7374
1990's219 (47.30)18.2507
2000's105 (22.68)29.6817
2010's27 (5.83)24.3611
2020's3 (0.65)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.57

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.57 (24.57)
Research Supply Index6.18 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.57)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews15 (3.13%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other465 (96.88%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]